Prevalence of Factor V Leiden in Young Adults with Retinal Vein Occlusion

Tuuli Linna; Antti Ylikorkala; Kimmo E Kontula; Päivi Puska; Timo Tervo

doi:10.1055/s-0038-1655933

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1997; 77(01): 214-216
DOI: 10.1055/s-0038-1655933

Letter to the Editor

Schattauer GmbH Stuttgart

Prevalence of Factor V Leiden in Young Adults with Retinal Vein Occlusion

Tuuli Linna

¹The Department of Ophthalmology, University of Helsinki, Finland

,

Antti Ylikorkala

²The Department of Medicine, University of Helsinki, Finland

,

Kimmo E Kontula

²The Department of Medicine, University of Helsinki, Finland

,

Päivi Puska

¹The Department of Ophthalmology, University of Helsinki, Finland

,

Timo Tervo

¹The Department of Ophthalmology, University of Helsinki, Finland

› Institutsangaben

Abstract

als PDF herunterladen

PDF (1024 kb)

Referenzen

References
1 Sanborn GE, Magargal LE, Jaeger EA. Venous occlusive disease of the retina. In: Duane's Clinical Ophthalmology, Diseases of the Retina, Glaucoma (Vol 3). Tasman W. ed. 1994 JB Lippincott Company; Philadelphia: 1994. pp 1-29
2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
3 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
4 Koster T, Rosendaal FR, de RondeH, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
5 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
6 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van der VeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
7 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
8 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
9 Hakala L, Vahtera E, Krusius T, Rasi V. APC-resistenssi ja hyytymistekijä V:n mutaatio suomalaisilla tromboosipotilailla (in Finnish). Duodecim 1995; 22: 2143-2151
10 Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Brit J Ophthalmol 1996; 80: 200-202
11 Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Brit J Ophthalmol 1996; 80: 203-208
12 de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886
13 Engel H, Zwang L, van VlietHHDM, Michiels JJ, Stibbe J, Lindemans J. Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 1996; 75: 267-269
14 Alhadyan AA. Retinal vein occlusion in Saudi-Arabia: possible role of dehydration. Ann Ophthalmol 1993; 25: 394-398